Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures

被引:137
作者
Wiegand, Irith
Geiss, Heinrich K.
Mack, Dietrich
Stuerenburg, Enno
Seifert, Harald
机构
[1] Univ Cologne, Inst Med Microbiol Immunol & Hyg, D-50935 Cologne, Germany
[2] Univ Bonn, Dept Med Microbiol Immunol & Parasitol, Pharmaceut Microbiol Unit, D-5300 Bonn, Germany
[3] Heidelberg Univ, Sect Infectiol, Inst Hyg, Heidelberg, Germany
[4] Univ Coll Swansea, Sch Med, Swansea SA2 8PP, W Glam, Wales
[5] Univ Hamburg, Hosp Eppendorf, Inst Med Microbiol Virol & Hyg, Ctr Clin Pathol, D-20246 Hamburg, Germany
关键词
D O I
10.1128/JCM.01988-06
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Three commercially available microbiology identification and susceptibility testing systems were compared with regard to their ability to detect extended-spectrum P-lactamase (ESBL) production in Enterobacteriaceae, i.e., the Phoenix Automated Microbiology System (BD Diagnostic Systems, Sparks, MD), the VITEK 2 System (bioMerieux, Marcy l'Etoile, France), and the MicroScan WalkAway-96 System (Dade Behring, Inc., West Sacramento, CA), using routine testing panels. One hundred fifty putative ESBL producers were distributed blindly to three participating laboratories. Conventional phenotypic confirmatory tests such as the disk approximation method, the CLSI double-disk synergy test, and the Etest ESBL were also evaluated. Biochemical and molecular characterization of beta-lactamases performed at an independent laboratory was used as the reference method. One hundred forty-seven isolates of Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter cloacae, Enterobacter aerogenes, Citrobacter freundii, Serratia marcescens, Proteus mirabilis, Proteus vulgaris, and Morganella morganii were investigated. Of these isolates, 85 were identified as ESBL producers by the reference method. The remaining isolates were identified as non-ESBL producers; they were either hyperproducers of their chromosomal AmpC, Koxy, or SHV enzymes or lacked any detectable P-lactamase activity. The system with the highest sensitivity for the detection of ESBLs was the Phoenix (99%), followed by the VITEK 2 (86%) and the MicroScan (84%); however, specificity was more variable, ranging from 52% (Phoenix) to 78% (VITEK 2). The performance of the semiautomated systems differed widely with the species investigated. The sensitivities of the conventional test methods ranged from 93 to 94%. The double-disk synergy test showed the highest specificity and positive predictive value among all test methods, i.e., 97% and 98%, respectively.
引用
收藏
页码:1167 / 1174
页数:8
相关论文
共 29 条
  • [11] Evaluation of four commercially available extended-spectrum beta-lactamase phenotypic confirmation tests
    Linscott, AJ
    Brown, WJ
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (03) : 1081 - 1085
  • [12] The β-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter
    Livermore, David M.
    Woodford, Neil
    [J]. TRENDS IN MICROBIOLOGY, 2006, 14 (09) : 413 - 420
  • [13] Detection of β-lactamase-mediated resistance
    Livermore, DM
    Brown, DFJ
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 : 59 - 64
  • [14] Detection of extended-spectrum β-lactamases in members of the family Enterobacteriaceae:: comparison of the MAST DD test, the double disc and the Etest ESBL
    M'Zali, FH
    Chanawong, A
    Kerr, KG
    Birkenhead, D
    Hawkey, PM
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (06) : 881 - 885
  • [15] Detection of genes coding for extended-spectrum SHV beta-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test
    NueschInderbinen, MT
    Hachler, H
    Kayser, FH
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1996, 15 (05) : 398 - 402
  • [16] Extended-spectrum β-lactamases:: a clinical update
    Paterson, DL
    Bonomo, RA
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 2005, 18 (04) : 657 - +
  • [17] PETER K, 1988, REV INFECT DIS, V10, P800
  • [18] Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community
    Pitout, JDD
    Nordmann, P
    Laupland, KB
    Poirel, L
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (01) : 52 - 59
  • [19] False-positive extended-spectrum β-lactamase tests for Klebsiella oxytoca strains hyperproducing K1 β-lactamase
    Potz, NAC
    Colman, M
    Warner, M
    Reynolds, R
    Livermore, DM
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (03) : 545 - 547
  • [20] Characterization of clinical isolates of Enterobacteriaceae from Italy by the BD phoenix extended-spectrum β-lactamase detection method
    Sanguinetti, M
    Posteraro, B
    Spanu, T
    Ciccaglione, D
    Romano, L
    Fiori, B
    Nicoletti, G
    Zanetti, S
    Fadda, G
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (04) : 1463 - 1468